Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05056896 · ClinicalTrials.gov registry record · Early Phase 1

ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension

A Early Phase 1 study of Colorectal Cancer, sponsored by Massachusetts General Hospital.

Active
Registry status
Early Phase 1
Development phase
161
Enrollment target
1
Study location

NCT05056896: Active Early Phase 1 study of Colorectal Cancer, sponsored by Massachusetts General Hospital.

NCT05056896 is a Early Phase 1 study of Colorectal Cancer that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 161 participants, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05056896, a Early Phase 1 study of Colorectal Cancer, is active but no longer recruiting, sponsored by Massachusetts General Hospital.

ACTIVE NOT RECRUITING
Registry status
Early Phase 1
Development phase
161 participants
Enrollment target
1
Study location

Study Summary

This research study is studying a drug intervention as a possible chemoprevention strategy for colorectal cancer. The name of the study intervention involved in this study is: * Low Dose Aspirin

Conditions Studied

Colorectal Cancer

Interventions

  • OTHER Placebo
  • DRUG Aspirin

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital Cancer Center - Boston

Trial Details

FieldValue
Enrollment Target 161 participants
Start Date 2022-06-03
Est. Completion 2026-12-31
Phase Early Phase 1

Sponsor

Massachusetts General Hospital

2,032 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05056896

The ClinicalTrials.gov registry entry for NCT05056896 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 161 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,511-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (89% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT05056896 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05056896 about?

NCT05056896 is a clinical study titled "ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension". This research study is studying a drug intervention as a possible chemoprevention strategy for colorectal cancer. The name of the study intervention involved in this study is: * Low Dose Aspirin

What is the current status of trial NCT05056896?

This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 161 participants. The study started on 2022-06-03. Estimated completion is 2026-12-31.

What conditions does trial NCT05056896 study?

This clinical trial studies the following conditions: Colorectal Cancer.

What interventions are being tested in trial NCT05056896?

The interventions under investigation include: Placebo (OTHER), Aspirin (DRUG).

Who is sponsoring clinical trial NCT05056896?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05056896 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Colorectal Cancer

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.